BioSpace News Archive

Deals

Viva Biotech’s Portfolio Company DTx Pharma Reached the Acquisition Agreement with Novartis

DTx Pharma, invested and incubated by Viva BioInnovator, is a preclinical stage biotechnology company addressing the delivery challenges of oligonucleotide therapeutics with its Fatty Acid Ligand Conjugated OligoNucleotide platform.

July 18, 2023
·
7 min read
Sobi publishes Q2 2023 report: Growth and pipeline expansion

Swedish Orphan Biovitrum AB announced its report for the second quarter 2023

July 18, 2023
·
3 min read
Genetown

BVI Expands IOL Capacity with New State of the Art Facility in Belgium

BVI, one of the fastest growing surgical ophthalmic businesses in the world, is proud to announce the opening of its new, state of the art facility in Liège, Belgium.

July 18, 2023
·
2 min read
2nd ZAODX World Conference on Early Detection of Cancer to Take Place in September 2023

The 2nd ZAODX World Conference on Early Detection of Cancer will take place on-site at the Huangpu International Conference Center, Guangzhou, China, and online in a virtual format from 15 to 17 September, 2023.

July 18, 2023
·
2 min read
BioCapital

Angry@Arthritis Launches 1st Global Osteoarthritis Clinical Trial Locator

Angry@Arthritis, a nonprofit focused on attacking and eliminating Osteoarthritis, announced OA Fix ~Trials in the Mix, the first global OA developmental treatment analysis and clinical trial locator.

July 18, 2023
·
3 min read
Drug Development

Neumora Therapeutics Announces Initiation of Phase 3 Clinical Program for Navacaprant (NMRA-140) in Major Depressive Disorder

Neumora Therapeutics, Inc. announced the planned initiation of the KOASTAL Program, a Phase 3 pivotal clinical program designed to evaluate the efficacy and safety of navacaprant monotherapy for the treatment of major depressive disorder.

July 18, 2023
·
9 min read
BioMidwest

EndoTheia Announces Successful Clinical Study Results for a Novel Medical Device for Endoscopic Surgery

EndoTheia, Inc. has announced the completion of a successful first-in-human clinical study performed at Vanderbilt University for their groundbreaking technology that radically improves minimally invasive endoscopic surgery.

July 18, 2023
·
3 min read
BSF Enterprise PLC Provides City-MixTM Bio-Pharmaceutical Update

BSF Enterprise PLC, a company focused on unlocking the next generation of biotechnological solutions using cell-based tissue engineering, provides a commercial update on the progress of City-MixTM, the flagship commercial product of its wholly owned subsidiary 3D Bio Tissues.

July 18, 2023
·
6 min read
Lone Star Bio

Castle Biosciences to Host Second Annual Castle Cares Charity Walk

Castle Biosciences, Inc. announced that it will host its second company-wide Castle Cares Charity Walk today, Tuesday, July 18, 2023, in Orlando, Florida.

July 18, 2023
·
2 min read
Business

OrthoPediatrics Corp. to Report Second Quarter 2023 Financial Results on August 1, 2023

OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced that the Company is scheduled to release its second quarter 2023 financial results on Monday, July 31st, 2023, after the market closes.

July 18, 2023
·
1 min read